In 2004, Don Conway established the Health Care Initiative at The Tuck School where he leads collaborative efforts of the Geisel School of Medicine and The Tuck School of Business. These efforts are focused on addressing the business issues facing the health care industry. Dr. Conway also teaches the following MBA courses: The Business of Healthcare; Structure, Organization and Economics of the Healthcare Industry; and Contemporary Issues in Biotechnology.
Prior to his appointment, Dr. Conway was Head of Global Health Economics and Research Outcomes for Aventis Pharma. In this position, his primary role was to develop analyses of practice patterns, practice guidelines, Cost-Effectiveness and Quality of Life Studies. These efforts were focused on demonstrating the true value argument and cost effectiveness. Through an understanding of the cost offsets (fewer hospitalizations, shorter length of stay, fewer after visits and more rapid return to work or usual activities), the true value of medical therapies is best appreciated. Dr. Conway participated in clinical trials by helping to define the appropriate patient population and key indications, which best demonstrated the value of treatments. He performed the requisite analyses to ensure that data are included in the economic dossiers around the world, including submission to NICE (the UK’s National Institute for Clinical Excellence). He met with regulatory authorities for pricing and reimbursement and led negotiating on behalf of Aventis.
Prior to joining Aventis, Dr. Conway was Global Director of Epidemiology and Health Outcomes Research for Abbott Laboratories. In 1989, Dr. Conway established the Department of Technology Management for the American Medical Association, which was American Medicine’s first dedicated venture in Health Technology Assessment. His duties for the AMA also included developing Health Policy and he has represented the medicine’s interest before US Congress, the FDA and CMS.
Dr. Conway has served as chairman of the multinational, Global Health Policy Group. He has actively participated in Managed Care Advisory Boards covering both product related and Quality Care issues and has conducted Quality Improvement studies in managed care, and academic medical center settings (Massachusetts General Hospital). In 2002 Dr. Conway was voted onto PhRma’s Health Outcomes Committee which formulates health policies and practices.
Dr. Conway received his Doctor of Medicine (MD) and clinical training from Rush Medical College in Chicago and holds an MBA from the Tuck School of Business at Dartmouth College. Dr. Conway is an Adjunct Associate Professor of Community and Family Medicine at the Geisel School of Medicine and an Adjunct Associate Professor at the Tuck School.
Dr. Conway has published articles in American Medical Associate (JAMA), and the Annals of Internal Medicine. He is a member of the executive board of the National Patient Advocate Foundation and along with Professor Mike Zubkoff is Co-Director of Dartmouth’s MD-MBA joint degree program.